Despite a net loss and cash constraints, HeartBeam Inc (BEAT) remains optimistic about FDA clearance and its groundbreaking ECG technology.

HeartBeam (NASDAQ: BEAT), reported steady progress in its third quarter financial and operational results, advancing its cardiac care technology through key FDA 510(k) submissions and strategic ...

Leading the Way in ECG Technology Norav Medical is at the forefront of advancing ECG systems, offering a comprehensive range of cardiac diagnostic solutions tailored for both clinical and home use.

SANTA CLARA, Calif., November 07, 2024 -- ( BUSINESS WIRE )-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company ...

Northwestern Medicine will be the first system to use Tempus' new algorithm to identify patients at risk for developing ...

HeartBeam (NASDAQ: BEAT) , a medical technology company focused on enhancing cardiac care through advanced insights, will hold a conference call on November 7, 2024, at 4:30 p.m. ET to discuss ...

STMicroelectronics, has introduced a new bio-sensing chip for the next generations of healthcare wearables like smart watches ...

All patients had high-sensitivity troponin test results within 6 hours after 12-lead ECG. Both troponin I (TnI) and TnT were ...

It is notable that the ECG obtained at presentation showed the presumed sinus rhythm with first-degree atrioventricular block (PR interval, 230 milliseconds), along with right bundle-branch block and ...

Geneva, Switzerland, October 28, 2024 - STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers ...

The Company’s first application of its vector-based technology is a cable-free, credit card-sized device that is designed to ...

A detailed description of the study populations and methods have been published elsewhere. [1,4] Briefly for the purposes of the present investigation, data from 69 patients, 28 with AN, 28 ...